The Association between MTHFR Gene Polymorphisms and Hepatocellular Carcinoma Risk: A Meta-Analysis

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Qin, Xue ^a   Peng, Qiliu ^a,c   Chen, Zhiping ^b   Deng, Yan ^a   Huang, Shan ^a   Xu, Juanjuan ^a   Li, Haiwei ^a   Li, Shan ^a   Zhao, Jinmin ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

^c Baise People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ARTICLE; CANCER RISK; CASE CONTROL STUDY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MTHFR GENE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PROTECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SYSTEMATIC REVIEW;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84874009492     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056070     Document Type: Article

References (40)

1. Parkin DM, Bray F, Ferlay J, Pisani P, (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
2. Parkin DM, (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118: 3030-3044.
3. Kamen B, (1997) Folate and antifolate pharmacology. Semin Oncol 24: S18-30-S18-39.
4. Heijmans BT, Boer JM, Suchiman HE, Cornelisse CJ, Westendorp RG, et al. (2003) A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer. Cancer Res 63: 1249-1253.
5. Zintzaras E, (2006) Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysis. Clin Genet 69: 327-336.
6. Rosenblatt DS, (2001) Methylenetetrahydrofolate reductase. Clin Invest Med 24: 56-59.
7. Taioli E, Garza MA, Ahn YO, Bishop DT, Bost J, et al. (2009) Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review. Am J Epidemiol 170: 1207-1221.
8. Boccia S, Hung R, Ricciardi G, Gianfagna F, Ebert MP, et al. (2008) Meta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review. Am J Epidemiol 167: 505-516.
9. Kim YI, (2005) 5,10-Methylenetetrahydrofolate reductase polymorphisms and pharmacogenetics: a new role of single nucleotide polymorphisms in the folate metabolic pathway in human health and disease. Nutr Rev 63: 398-407.
10. Goyette P, Pai A, Milos R, Frosst P, Tran P, et al. (1998) Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm Genome 9: 652-656.
11. Guenther BD, Sheppard CA, Tran P, Rozen R, Matthews RG, et al. (1999) The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia. Nat Struct Biol 6: 359-365.
12. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, et al. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10: 111-113.
13. Pereira AC, Schettert IT, Morandini Filho AA, Guerra-Shinohara EM, Krieger JE, (2004) Methylenetetrahydrofolate reductase (MTHFR) c677t gene variant modulates the homocysteine folate correlation in a mild folate-deficient population. Clin Chim Acta 340: 99-105.
14. van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, et al. (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62: 1044-1051.
15. Jin F, Qu LS, Shen XZ, (2009) Association between the methylenetetrahydrofolate reductase C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis. Diagn Pathol 4: 39.
16. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-2012.
17. Thakkinstian A, McEvoy M, Minelli C, Gibson P, Hancox B, et al. (2005) Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 162: 201-211.
18. Higgins JP, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
19. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
20. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
21. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
22. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
23. Duval S, Tweedie R, (2000) Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56: 455-463.
24. Yu MC, Yuan JM, Lu SC, (2008) Alcohol, cofactors and the genetics of hepatocellular carcinoma. J Gastroenterol Hepatol 23Suppl 1: S92-97.
25. Samonakis DN, Koutroubakis IE, Sfiridaki A, Malliaraki N, Antoniou P, et al. (2004) Hypercoagulable states in patients with hepatocellular carcinoma. Dig Dis Sci 49: 854-858.
26. Saffroy R, Pham P, Chiappini F, Gross-Goupil M, Castera L, et al. (2004) The MTHFR 677C>T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis. Carcinogenesis 25: 1443-1448.
27. Ventura P, Rosa MC, Abbati G, Marchini S, Grandone E, et al. (2005) Hyperhomocysteinaemia in chronic liver diseases: role of disease stage, vitamin status and methylenetetrahydrofolate reductase genetics. Liver Int 25: 49-56.
28. Zhu ZZ, Cong WM, Liu SF, Xian ZH, Wu WQ, (2006) [A study on the association of MTHFR C677T polymorphism with genetic susceptibility to hepatocellular carcinoma]. Zhonghua Gan Zang Bing Za Zhi 14: 196-198.
29. Mu LN, Cao W, Zhang ZF, Cai L, Jiang QW, et al. (2007) Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese population. Cancer Causes Control 18: 665-675.
30. Yuan JM, Lu SC, Van Den Berg D, Govindarajan S, Zhang ZQ, et al. (2007) Genetic polymorphisms in the methylenetetrahydrofolate reductase and thymidylate synthase genes and risk of hepatocellular carcinoma. Hepatology 46: 749-758.
31. Kwak SY, Kim UK, Cho HJ, Lee HK, Kim HJ, et al. (2008) Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population. Anticancer Res 28: 2807-2811.
32. D'Amico M, Pasta L, Sammarco P, (2009) MTHFR C677TT, PAI1 4G-4G, V Leiden Q506, and prothrombin G20210A in hepatocellular carcinoma with and without portal vein thrombosis. J Thromb Thrombolysis 28: 70-73.
33. Fabris C, Toniutto P, Falleti E, Fontanini E, Cussigh A, et al. (2009) MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption. Alcohol Clin Exp Res 33: 102-107.
34. Cui LH, Song Y, Si H, Shen F, Shin MH, et al. (2011) Folate metabolism-related gene polymorphisms and susceptibility to primary liver cancer in North China. Med Oncol.
35. Liu JJ, Gao YT, Du Z, Yang B, Jing X, et al. (2010) Shi Jie Hua Ren Xiao Hua Za Zhi, 2010. Shi Jie Hua Ren Xiao Hua Za Zhi 18: 1555-1562 (article in chinese). Available: http://d.g.wanfangdata.com.cn/Periodical_hrxhzz201015007.aspx. Accessed 2012 June 10.
36. Yang H (2007) Genetic association between candidate genes polymorphisms and susceptibility to chronic hepatitis B, hepatocellular carcinoma and nasopharyngeal carcinoma in Chinese population (article in chinese). Available at http://d.g.wanfangdata.com.cn/Thesis_Y1201379.aspx (accessed 10 June 2012).
37. Friso S, Choi SW, Girelli D, Mason JB, Dolnikowski GG, et al. (2002) A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci U S A 99: 5606-5611.
38. Botto LD, Yang Q, (2000) 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151: 862-877.
39. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R, (1998) A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64: 169-172.
40. Bagley PJ, Selhub J, (1998) A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. Proc Natl Acad Sci U S A 95: 13217-13220.